Milestone Pharmaceuticals gets NMPA approval for etripamil
Milestone Pharmaceuticals announced NMPA approval of etripamil nasal spray for adult PSVT and a $2.0 million milestone payment.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.
News Feed
2 results loaded, newest first. End of these results. The latest changes are still being indexed. Try again shortly for updated results.
Milestone Pharmaceuticals gets NMPA approval for Etripamil nasal spray in China
Milestone Pharmaceuticals said China’s NMPA approved its etripamil nasal spray for PSVT, the first Etripamil regulatory approval outside the United States.